Market Place
Sourcing Support
YD Bio CEO Dr. Ethan Shen Unveils Oncology Ecosystem Strategy
17 Mar 2026 //
GLOBENEWSWIRE
YD Bio, YC Bio Partner on Taiwan-US Dual-Core Regulatory Platform
25 Feb 2026 //
GLOBENEWSWIRE
YD Bio`s LOI with SafeSave Bolsters Immunocell Therapy
29 Jan 2026 //
GLOBENEWSWIRE
YD Bio, EG BioMed Sign AI Cancer Merger MOU
06 Jan 2026 //
GLOBENEWSWIRE
YD Bio Unveils Major Milestones, 2026 Roadmap
05 Jan 2026 //
GLOBENEWSWIRE
YD Bio Expands U.S. Footprint with New California Sites
16 Dec 2025 //
GLOBENEWSWIRE
YD Bio Showcases Portfolios at Taiwan`s 9th Healthcare Expo
09 Dec 2025 //
GLOBENEWSWIRE
YD Bio Expands OkaiDx to Detect Pancreatic, Colorectal Cancers
02 Dec 2025 //
GLOBENEWSWIRE
YD Bio Enters US Ophthalmology Market With Diagnostics & LSC Tx
24 Nov 2025 //
GLOBENEWSWIRE
YD Bio & EG Biomed Expand U.S. Access To Okaidx
06 Nov 2025 //
GLOBENEWSWIRE
YD Bio Rings Nasdaq Bell For YDES Listing
20 Oct 2025 //
GLOBENEWSWIRE
YD Bio Partner EG Biomed Gains CAP, Boosting US Clinical Testing
10 Oct 2025 //
GLOBENEWSWIRE
Yd Bio Limited Reports Unaudited Half Year 2025 Financial Results
30 Sep 2025 //
GLOBENEWSWIRE
YD Bio Completes Merger, Lists on Nasdaq Global Market
29 Aug 2025 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.